Jan Matthias Kruse
Overview
Explore the profile of Jan Matthias Kruse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Opper Hernando M, Witham D, Stahl A, Steinhagen P, Angermair S, Bauer W, et al.
Insights Imaging
. 2025 Jan;
16(1):15.
PMID: 39804413
Objectives: To survey physicians' views on the risks and benefits of computed tomography (CT) in the management of septic patients and indications for and contraindications to contrast media use in...
2.
Leonhardt S, Jurgensen C, Frohme J, Grajecki D, Adler A, Sigal M, et al.
Hepatol Int
. 2023 Apr;
17(6):1610-1625.
PMID: 37119516
Background: Increasing evidence suggests that secondary sclerosing cholangitis (SSC), which can lead to cirrhosis or liver failure, may be a hepatobiliary long-term complication of COVID-19. The aim of this study...
3.
Korper S, Gruner B, Zickler D, Wiesmann T, Wuchter P, Blasczyk R, et al.
J Clin Invest
. 2022 Nov;
132(24).
PMID: 36326824
BACKGROUNDResults of many randomized trials on COVID-19 convalescent plasma (CCP) have been reported, but information on long-term outcome after CCP treatment is limited. The objectives of this extended observation of...
4.
Korper S, Weiss M, Zickler D, Wiesmann T, Zacharowski K, Corman V, et al.
J Clin Invest
. 2021 Aug;
131(20).
PMID: 34464358
BACKGROUNDCOVID-19 convalescent plasma (CCP) has been considered a treatment option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing high-dose CCP in hospitalized adults with COVID-19 requiring...
5.
Kruse J, Zickler D, Ludemann W, Piper S, Gotthardt I, Ihlow J, et al.
Sci Rep
. 2021 Aug;
11(1):16039.
PMID: 34362979
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) induces lung injury of varying severity, potentially causing severe acute respiratory distress syndrome (ARDS). Pulmonary injury patterns in...
6.
Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19
Magomedov A, Zickler D, Karaivanov S, Kurreck A, Munch F, Kamhieh-Milz J, et al.
Sci Rep
. 2021 Jun;
11(1):13325.
PMID: 34172793
COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated....
7.
Schroeder T, Kruse J, Marcy F, Piper S, Storm C, Nee J
J Crit Care
. 2021 Jun;
65:49-55.
PMID: 34082255
Purpose: Chronic obstructive pulmonary disease (COPD) is a risk factor for acquiring multiple drug resistant bacteria. The main objective of this analysis was to question a beneficial outcome in the...
8.
Lerchbaumer M, Lauryn J, Bachmann U, Enghard P, Fischer T, Grune J, et al.
Sci Rep
. 2021 May;
11(1):10678.
PMID: 34021219
With an urgent need for bedside imaging of coronavirus disease 2019 (COVID-19), this study's main goal was to assess inter- and intraobserver agreement in lung ultrasound (LUS) of COVID-19 patients....
9.
Zickler D, Nee J, Arnold T, Schroder T, Slowinski T, Eckardt K, et al.
ASAIO J
. 2021 Feb;
67(11):e186-e190.
PMID: 33587468
Drugs intoxications often lead to severe vasoplegia and cardiogenic shock, and VA-ECMO represents a viable therapy option. However, as cardiopulmonary support is not contributing to the removal of the causal...
10.
Kruse J, Magomedov A, Kurreck A, Munch F, Koerner R, Kamhieh-Milz J, et al.
Crit Care
. 2020 Dec;
24(1):676.
PMID: 33287877
Background: There is emerging evidence for enhanced blood coagulation in coronavirus 2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and mortality. The mechanisms underlying this prothrombotic state remain enigmatic....